Related Experiment Videos
DAX-1 blocks steroid production at multiple levels
E Lalli1, M H Melner, D M Stocco
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université Louis Pasteur, Strasbourg, France.
Abstract:
DAX-1 is an unusual member of the nuclear hormone receptor superfamily whose expression is mainly, but not uniquely, restricted to steroidogenic tissues. We have recently shown that DAX-1 can block the first and rate-limiting step in steroid biosynthesis by repressing StAR (steroidogenic acute regulatory protein) expression. Here we show that DAX-1 blocks steroid production at multiple levels in the Y-1 mouse adrenocortical tumor cell line. Expression of DAX-1 in Y-1 cells significantly impairs both basal and cAMP-stimulated steroid production, without affecting the functionality of the cAMP-responsive PKA pathway. Experiments using an hydroxylated cholesterol derivative show that biochemical steps in steroidogenesis subsequent to cholesterol delivery to mitochondria are also impaired in Y-1 cells expressing DAX-1. This is explained by the repression of P450scc and 3beta-HSD expression, in addition to StAR. DAX-1 expression in Y-1 cells results in the inhibition of the activity of the StAR, P450scc and 3beta-HSD promoters. An inappropriate steroidogenic block in the male fetus might have an important role in the pathogenesis of sex reversal syndromes caused by a duplication of the genomic region of the X chromosome containing the DAX-1 gene.
Insights
DAX-1 protein inhibits steroid production by repressing key steroidogenic gene expression, including StAR, P450scc, and 3beta-HSD. This disruption can lead to sex reversal syndromes in males.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome gene 1) is a nuclear receptor superfamily member.
- DAX-1 expression is primarily found in steroidogenic tissues.
- Previous studies indicated DAX-1 represses steroidogenic acute regulatory protein (StAR) expression, a key step in steroid biosynthesis.
Purpose of the Study:
- To investigate the broader impact of DAX-1 on steroid production.
- To determine if DAX-1 affects steroidogenesis at multiple levels.
- To explore the role of DAX-1 in the pathogenesis of sex reversal.
Main Methods:
- Utilized Y-1 mouse adrenocortical tumor cells.
- Assessed basal and cAMP-stimulated steroid production.
- Examined the functionality of the cAMP-responsive PKA pathway.
- Used hydroxylated cholesterol derivatives to probe steroidogenesis.
- Measured expression of StAR, P450scc, and 3beta-HSD.
- Analyzed the activity of StAR, P450scc, and 3beta-HSD promoters.
Main Results:
- DAX-1 expression significantly impaired basal and cAMP-stimulated steroid production in Y-1 cells.
- The cAMP-responsive PKA pathway remained functional.
- Steroidogenic steps beyond cholesterol delivery to mitochondria were impaired.
- DAX-1 repressed the expression of StAR, P450scc, and 3beta-HSD.
- DAX-1 inhibited the promoter activity of StAR, P450scc, and 3beta-HSD.
Conclusions:
- DAX-1 inhibits steroid production at multiple levels by repressing StAR, P450scc, and 3beta-HSD expression and promoter activity.
- Dysregulation of steroidogenesis due to DAX-1 may contribute to sex reversal syndromes, particularly in males with X chromosome duplications.